Psychedelic stocks: focus on their cash
Sign up for free
Listen to this episode and many more. Enjoy the best podcasts on Spreaker!
Download and listen anywhere
Download your favorite episodes and enjoy them, wherever you are! Sign up or log in now to access offline listening.
Description
Jason Najum has https://seekingalpha.com/author/jason-najum?source=ie_podcast:psychedelic_stocks_focus_on_their_cash the psychedelic space for a long time and contextualizes recent https://seekingalpha.com/article/4711635-mindmed-and-other-psychedelic-stocks-brace-for-fdas-decision-on-mdma-therapy?source=ie_podcast:psychedelic_stocks_focus_on_their_cash around the FDA, MDMA, PTSD and Lykos Therapeutics (1:35). Recent news a blessing in disguise...
show moreRead episode transcripts
Show Notes:
FDA's MDMA Decision A Setback, But Long-Term Outlook For Psychedelic Stocks Unchanged
MindMed: Despite MDMA Setback, Still Hope In Light Of Differentiating Factors
ATAI: Enormous Potential Upside But No Clarity Yet
De-Risking Psychedelics: Compass Pathways, Cybin And Atai
For full access to analyst ratings, stock quant scores and dividend grades, subscribe to Seeking Alpha Premium at seekingalpha.com/subscriptions
Information
| Author | Seeking Alpha |
| Organization | Seeking Alpha |
| Website | seekingalpha.com |
| Tags |
Copyright 2024 - Spreaker Inc. an iHeartMedia Company
